{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:35:41Z","timestamp":1761514541255},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.0274","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:31:20Z","timestamp":1583166680000},"page":"e200274","source":"Crossref","is-referenced-by-count":7,"title":["Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries"],"prefix":"10.1001","volume":"3","author":[{"given":"Tanvi","family":"Rao","sequence":"first","affiliation":[{"name":"IMPAQ International LLC, Washington, District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zippora","family":"Kiptanui","sequence":"additional","affiliation":[{"name":"IMPAQ International LLC, Columbia, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dowell","sequence":"additional","affiliation":[{"name":"IMPAQ International LLC, Columbia, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Triebwasser","sequence":"additional","affiliation":[{"name":"IMPAQ International LLC, Wellesley, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilene","family":"Harris","sequence":"additional","affiliation":[{"name":"IMPAQ International LLC, Columbia, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"issue":"26","key":"zoi200025r1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015.","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"zoi200025r2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0665","article-title":"Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017.","volume":"2","author":"Schieber","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi200025r4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/SLA.0000000000001993","article-title":"Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures.","volume":"265","author":"Hill","year":"2017","journal-title":"Ann Surg"},{"issue":"3","key":"zoi200025r6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/jgs.2011.59.issue-3","article-title":"Opioid analgesics and the risk of fractures in older adults with arthritis.","volume":"59","author":"Miller","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"zoi200025r7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jgs.2013.61.issue-3","article-title":"Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults.","volume":"61","author":"Rolita","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"15","key":"zoi200025r9","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"zoi200025r11","first-page":"e95","article-title":"Effects of a Medicaid prior authorization policy for pregabalin.","volume":"15","author":"Margolis","year":"2009","journal-title":"Am J Manag Care"},{"key":"zoi200025r12","first-page":"e17","article-title":"Trends associated with implementing and lifting a pregabalin step therapy policy.","volume":"8","author":"Null","year":"2016","journal-title":"Am J Health Benefits"},{"key":"zoi200025r13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jpubeco.2018.07.006","article-title":"What happens when the insurer can say no? assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs.","volume":"165","author":"Dillender","year":"2018","journal-title":"J Public Econ"},{"issue":"3","key":"zoi200025r16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1526-4637.2011.01061.x","article-title":"The role of the health insurance industry in perpetuating suboptimal pain management.","volume":"12","author":"Schatman","year":"2011","journal-title":"Pain Med"},{"issue":"2","key":"zoi200025r17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0235","article-title":"Prescription drug coverage for treatment of low back pain among US Medicaid, Medicare Advantage, and commercial insurers.","volume":"1","author":"Lin","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi200025r18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0236","article-title":"Opioid prescribing for low back pain: what is the role of payers?","volume":"1","author":"Waljee","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi200025r19","first-page":"e242","article-title":"Using clinically nuanced cost sharing to enhance consumer access to specialty medications.","volume":"20","author":"Buxbaum","year":"2014","journal-title":"Am J Manag Care"},{"issue":"4","key":"zoi200025r20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.2019.67.issue-4","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"zoi200025r22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.7326\/M17-1823","article-title":"Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015.","volume":"167","author":"Samuels","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi200025r23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s11606-018-4752-8","article-title":"Medicare formulary coverage and restrictions for opioid potentiators from 2013 to 2017.","volume":"34","author":"Vijay","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi200025r24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3044","article-title":"Coverage of nonpharmacologic treatments for low back pain among US public and private insurers.","volume":"1","author":"Heyward","year":"2018","journal-title":"JAMA Netw Open"},{"key":"zoi200025r8","volume-title":"Prescription Drug Abuse Among Older Adults","author":"AARP Public Policy Institute","year":"2017"},{"key":"zoi200025r3","unstructured":"Centers for Disease Control and Prevention. US Opioid prescribing rate maps. https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate-maps.html. Published 2017. Accessed July 1, 2019."},{"key":"zoi200025r5","unstructured":"US Department of Health & Human Service, Office of Inspector General. Opioid use in Medicare Part D remains concerning. https:\/\/oig.hhs.gov\/oei\/reports\/oei-02-18-00220.pdf. Published June 2018. Accessed January 25, 2020."},{"key":"zoi200025r10","unstructured":"US Department of Health and Human Services. 5-Point strategy to combat the opioid crisis. https:\/\/www.hhs.gov\/opioids\/about-the-epidemic\/hhs-response\/index.html. Published 2018. Accessed July 1, 2019."},{"key":"zoi200025r14","unstructured":"MattersMLN. A prescriber\u2019s guide to the new Medicare Part D opioid overutilization policies for 2019. https:\/\/www.cms.gov\/Outreach-and-Education\/Medicare-Learning-Network-MLN\/MLNMattersArticles\/Downloads\/se18016.pdf. Published November 1, 2018. Accessed July 1, 2019."},{"key":"zoi200025r15","unstructured":"ThomasK, OrnsteinC. Amid opioid crisis, insurers restrict pricey, less addictive painkillers. The New York Times. https:\/\/www.nytimes.com\/2017\/09\/17\/health\/opioid-painkillers-insurance-companies.html. Published September 17, 2017. Accessed July 1, 2019."},{"key":"zoi200025r21","unstructured":"Centers for Medicare & Medicaid Services. Medicare Part D opioid prescribing mapping tool. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/Medicare-Provider-Charge-Data\/OpioidMap_Medicare_PartD.html. Updated May 1, 2019. Accessed July 1, 2019."},{"key":"zoi200025r25","unstructured":"SkellyAC, ChouR, DettoriJR, . Noninvasive nonpharmacological treatment for chronic pain: a systematic review. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519953\/. Published June 2018. Accessed July 1, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2761796\/rao_2020_oi_200025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:31:25Z","timestamp":1583166685000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2761796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.0274","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]}}}